DrugPatentWatch Database Preview
QMIIZ ODT Drug Profile
» See Plans and Pricing
Which patents cover Qmiiz Odt, and what generic alternatives are available?
Qmiiz Odt is a drug marketed by Tersera and is included in one NDA. There is one patent protecting this drug.
This drug has one patent family member in one country.
The generic ingredient in QMIIZ ODT is meloxicam. There are twenty-two drug master file entries for this compound. Thirty-four suppliers are listed for this compound. Additional details are available on the meloxicam profile page.
US ANDA Litigation and Generic Entry Outlook for Qmiiz Odt
A generic version of QMIIZ ODT was approved as meloxicam by CIPLA on July 19th, 2006.
Summary for QMIIZ ODT
| International Patents: | 1 |
| US Patents: | 1 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: | 1 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | QMIIZ ODT at DailyMed |
Pharmacology for QMIIZ ODT
| Drug Class | Nonsteroidal Anti-inflammatory Drug |
| Mechanism of Action | Cyclooxygenase Inhibitors |
US Patents and Regulatory Information for QMIIZ ODT
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tersera | QMIIZ ODT | meloxicam | TABLET, ORALLY DISINTEGRATING;ORAL | 211210-001 | Oct 19, 2018 | DISCN | Yes | No | Start Trial | Start Trial | Y | Start Trial | |||
| Tersera | QMIIZ ODT | meloxicam | TABLET, ORALLY DISINTEGRATING;ORAL | 211210-002 | Oct 19, 2018 | DISCN | Yes | No | Start Trial | Start Trial | Y | Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for QMIIZ ODT
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| World Intellectual Property Organization (WIPO) | 2011026080 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
